Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;18(4):393-401.
doi: 10.2217/pgs-2016-0174. Epub 2017 Feb 22.

The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial

Susanne Jh Vijverberg  1 , Mariëlle W Pijnenburg  2 , Anke M Hövels  3 , Gerard H Koppelman  4   5 , Anke-Hilse Maitland-van der Zee  1
Affiliations
Review

The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial

Susanne Jh Vijverberg et al. Pharmacogenomics. 2017 Mar.

Abstract

A 'one-size fits all'-approach does not fit all pediatric asthma patients. Current evidence suggests that in children with persistent asthma, ADRB2 genotype-guided treatment can improve treatment outcomes, yet this evidence is mainly derived from observational and genotype-stratified studies. Implementation of precision medicine-guided asthma treatment in clinical practice will only occur if randomized clinical trials can show that this approach will improve patient outcomes and is cost effective. In this paper, we will discuss why precision medicine trials are currently needed to improve childhood asthma management and present the rationale and design of the PUFFIN trial, that has been set up to address this need.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Omics for the future in asthma.
    Abdel-Aziz MI, Neerincx AH, Vijverberg SJ, Kraneveld AD, Maitland-van der Zee AH. Abdel-Aziz MI, et al. Semin Immunopathol. 2020 Feb;42(1):111-126. doi: 10.1007/s00281-019-00776-x. Epub 2020 Jan 15. Semin Immunopathol. 2020. PMID: 31942640 Review.
  • ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.
    Karimi L, Vijverberg SJ, Engelkes M, Hernandez-Pacheco N, Farzan N, Soares P, Pino-Yanes M, Jorgensen AL, Eng C, Mukhopadhyay S, Schieck M, Kabesch M, Burchard EG, Chew FT, Sio YY, Potočnik U, Gorenjak M, Hawcutt DB, Palmer CN, Turner S, Janssens HM, Maitland-van der Zee AH, Verhamme KMC; PiCA and SysPharmPedia consortia. Karimi L, et al. Clin Exp Allergy. 2021 Sep;51(9):1157-1171. doi: 10.1111/cea.13965. Epub 2021 Jul 20. Clin Exp Allergy. 2021. PMID: 34128573 Free PMC article.
  • Genotype-Guided Asthma Treatment Reduces Exacerbations in Children: Meta-Analysis of Two Randomized Control Trials.
    Slob EMA, Vijverberg SJH, Ruffles T, Noij LCE, Biermann J, Brouwer AFJ, van den Brink K, de Bruin-Kok A, Van Ewijk BE, Haarman E, Hammer SC, Hashimoto S, Hogarth F, Jones CJ, Kamps AWA, Kersten ETG, de Kleer I, Lipworth BJ, Littleford R, Mérelle M, Moeller A, Palmer CNA, Pilvinyte K, Rutjes NW, van Schaik RHN, Smith HE, Tavendale R, Terheggen-Lagro SWJ, Turner S, Twisk JWR, Vaessen-Verberne A, Verwaal M, de Vries T, Wesseling J, Pijnenburg MW, Koppelman GH, Mukhopadhyay S, Maitland-van der Zee AH. Slob EMA, et al. Allergy. 2025 Apr;80(4):1006-1014. doi: 10.1111/all.16438. Epub 2024 Dec 26. Allergy. 2025. PMID: 39723595 Free PMC article.
  • Genome-wide association studies of exacerbations in children using long-acting beta2-agonists.
    Slob EMA, Richards LB, Vijverberg SJH, Longo C, Koppelman GH, Pijnenburg MWH, Bel EHD, Neerincx AH, Herrera Luis E, Perez-Garcia J, Tim Chew F, Yie Sio Y, Andiappan AK, Turner SW, Mukhopadhyay S, Palmer CNA, Hawcutt D, Jorgensen AL, Burchard EG, Hernandez-Pacheco N, Pino-Yanes M, Maitland-van der Zee AH. Slob EMA, et al. Pediatr Allergy Immunol. 2021 Aug;32(6):1197-1207. doi: 10.1111/pai.13494. Epub 2021 Mar 29. Pediatr Allergy Immunol. 2021. PMID: 33706416 Free PMC article.
  • ADRB2 genotype-guided treatment for childhood asthma: Cost analysis of the PUFFIN and PACT trials.
    Slob EMA, Frederix GWJ, Vijverberg SJH, Noij LCE, Ruffles T, Vasbinder EC, Mukhopadhyay S, van Schaik RHN, Kersten ETG, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH; PUFFIN and PACT investigators. Slob EMA, et al. Pediatr Allergy Immunol. 2025 Jun;36(6):e70113. doi: 10.1111/pai.70113. Pediatr Allergy Immunol. 2025. PMID: 40464075 Free PMC article. Clinical Trial.
See all "Cited by" articles

Substances

LinkOut - more resources